Dáil
Written answer
Medicinal Products
Summary
The HSE, responsible for pricing and reimbursement decisions, was asked to provide information on approval timelines for rare disease medicines in Ireland and other EU countries.
1178. Deputy Pádraig O'Sullivan asked the Minister for Health the average length of time between European Medicines Agency approval and reimbursement approval in Ireland for rare disease and orphan medicines; and the way in which this compares with other EU countries. [64549/26]
